Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Breast Cancer Research 2008

Email this article to a friend

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes

S Wilkie, G Picco, J Foster, D Davies, S Julien, L Cooper, S Arif, S Mather, J Taylor-Papadimitriou, J Burchell and J Maher

Breast Cancer Research 2008, 10(Suppl 2):O6 doi:10.1186/bcr1881

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.